Inhibition of Akt pathway restores the sensitivity to cetuximab in a head and neck squamous cancer cell line

被引：0
|
作者：
Rebucci, M. [1 ]
Dewitte, A. [1 ]
Peixoto, P. [1 ]
Lartigau, E. [2 ]
Lansiaux, A. [3 ]
机构：
[1] INSERM, Ircl, U837, F-59045 Lille, France
[2] Ctr Oscar Lambret, Univ Dept Radiotherapy, F-59020 Lille, France
[3] Ctr Oscar Lambret Inserm, U837, Lille, France
来源：
EJC SUPPLEMENTS | 2010年 / 8卷 / 05期
关键词：
D O I：
10.1016/S1359-6349(10)71297-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
496
引用
收藏
页码：127 / 127
页数：1
相关论文
共 50 条
  • [1] Role of Akt pathway in the response of cetuximab in a resistant head and neck cell line
    Rebucci, Magali
    Peixoto, Paul
    De Witte, Amelie
    Dewas, Claire
    Lartigau, Eric
    Lansiaux, Amelie
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [2] Cetuximab and the Head and Neck Squamous Cell Cancer
    Concu, Riccardo
    Cordeiro, M. Natalia D. S.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2018, 18 (03) : 192 - 198
  • [3] Aurora Kinase Inhibition Overcomes Cetuximab Resistance in Squamous Cell Cancer of the Head and Neck
    Hoellein, Alexander
    Pickhard, Anja
    von Keitz, Fabienne
    Schoeffmann, Stephanie
    Piontek, Guido
    Rudelius, Martina
    Baumgart, Anja
    Wagenpfeil, Stefan
    Peschel, Christian
    Dechow, Tobias
    Bier, Henning
    Keller, Ulrich
    ONCOTARGET, 2011, 2 (08) : 599 - 609
  • [4] Variation of intrinsic cetuximab sensitivity in head and neck squamous cell carcinomas
    Jerhammar, F.
    Roberg, K.
    EJC SUPPLEMENTS, 2010, 8 (05): : 50 - 50
  • [5] The role of cetuximab in the treatment of squamous cell cancer of the head and neck
    Burtness, B
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2005, 5 (08) : 1085 - 1093
  • [6] Inhibition of STAT-3 results in greater cetuximab sensitivity in head and neck squamous cell carcinoma
    Bonner, James A.
    Yang, Eddy S.
    Trummell, Hoa Q.
    Nowsheen, Somaira
    Willey, Christopher D.
    Raisch, Kevin P.
    RADIOTHERAPY AND ONCOLOGY, 2011, 99 (03) : 339 - 343
  • [7] Cetuximab in squamous cell head and neck carcinomas
    Gebbia, V.
    Giuliani, F.
    Valori, V. M.
    Agueli, R.
    Coiucci, G.
    Maiello, E.
    ANNALS OF ONCOLOGY, 2007, 18 : 5 - 7
  • [8] Potentiation of cetuximab by inhibition of tregs in metastatic squamous cell cancers of head and neck
    Jha, Gautam
    Kademani, Deepak
    Miller, Jeffrey
    ORAL ONCOLOGY, 2013, 49 : S23 - S23
  • [9] POTENTIATION OF CETUXIMAB BY INHIBITION OF Tregs IN METASTATIC SQUAMOUS CELL CANCERS OF HEAD AND NECK
    Jha, Gautam
    Miller, Jeffrey
    ANTICANCER RESEARCH, 2014, 34 (10) : 5975 - 5977
  • [10] Cetuximab approved by FDA for treatment of head and neck squamous cell cancer
    不详
    CANCER BIOLOGY & THERAPY, 2006, 5 (04) : 340 - 342
12345